BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18604551)

  • 1. Symptom screening in detection of occupational solvent-related encephalopathy.
    Kaukiainen A; Akila R; Martikainen R; Sainio M
    Int Arch Occup Environ Health; 2009 Feb; 82(3):343-55. PubMed ID: 18604551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting chronic solvent encephalopathy in occupations at risk.
    Furu H; Sainio M; Hyvärinen HK; Akila R; Bäck B; Uuksulainen S; Kaukiainen A
    Neurotoxicology; 2012 Aug; 33(4):734-41. PubMed ID: 22560996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A screening programme on chronic solvent-induced encephalopathy among Dutch painters.
    Spee T; van Valen E; van Duivenbooden C; van der Laan G
    Neurotoxicology; 2012 Aug; 33(4):727-33. PubMed ID: 22664100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of periodical health examinations in detecting occupational chronic solvent encephalopathy.
    Furu HM; Sainio M; Hyvärinen HK; Kaukiainen A
    Occup Environ Med; 2019 Sep; 76(9):688-693. PubMed ID: 31320491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of detecting a chronic solvent encephalopathy case by screening.
    Furu H; Sainio M; Ahonen G; Hyvärinen HK; Kaukiainen A
    Neurotoxicology; 2014 Dec; 45():253-9. PubMed ID: 24463353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms of chronic solvent encephalopathy: Euroquest questionnaire study.
    Kaukiainen A; Hyvärinen HK; Akila R; Sainio M
    Neurotoxicology; 2009 Nov; 30(6):1187-94. PubMed ID: 19963103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral impairment in chronic solvent-induced encephalopathy.
    Visser I; Lavini C; Booij J; Reneman L; Majoie C; de Boer AG; Wekking EM; de Joode EA; van der Laan G; van Dijk FJ; Schene AH; Den Heeten GJ
    Ann Neurol; 2008 May; 63(5):572-80. PubMed ID: 18412121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Work ability score of solvent-exposed workers.
    Furu H; Sainio M; Hyvärinen HK; Kaukiainen A
    Int Arch Occup Environ Health; 2018 Jul; 91(5):559-569. PubMed ID: 29594340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic evaluation of workers previously diagnosed with solvent-induced toxic encephalopathy.
    Albers JW; Wald JJ; Garabrant DH; Trask CL; Berent S
    J Occup Environ Med; 2000 Apr; 42(4):410-23. PubMed ID: 10774510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Mäntylä R; Lamminen A; Hyvärinen HK; Sainio M
    Int Arch Occup Environ Health; 2009 Apr; 82(5):595-602. PubMed ID: 18936955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative EEG in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Kovala T; Holm A; Hyvärinen HK; Sainio M
    Hum Exp Toxicol; 2008 Apr; 27(4):315-20. PubMed ID: 18684802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision rules for assessment of chronic solvent-induced encephalopathy: Results in 2370 patients.
    Verberk MM; van der Hoek JA; van Valen E; Wekking EM; van Hout MS; Hageman G; van der Laan G; van Dijk FJ
    Neurotoxicology; 2012 Aug; 33(4):742-52. PubMed ID: 22722000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational chronic solvent encephalopathy in Finland 1995-2007: incidence and exposure.
    Keski-Säntti P; Kaukiainen A; Hyvärinen HK; Sainio M
    Int Arch Occup Environ Health; 2010 Aug; 83(6):703-12. PubMed ID: 19941001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solvent-related chronic toxic encephalopathy as a target in the worker's mental health research.
    Ramos A; Jardim SR; Silva-Filho JF
    An Acad Bras Cienc; 2004 Dec; 76(4):757-69. PubMed ID: 15558155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P300 of auditory event related potentials in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Holm A; Akila R; Tuisku K; Kovala T; Sainio M
    Neurotoxicology; 2007 Nov; 28(6):1230-6. PubMed ID: 17869344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxicity of solvents.
    Sainio MA
    Handb Clin Neurol; 2015; 131():93-110. PubMed ID: 26563785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics.
    van Valen E; van Thriel C; Akila R; Nilson LN; Bast-Pettersen R; Sainio M; van Dijk F; van der Laan G; Verberk M; Wekking E
    Neurotoxicology; 2012 Aug; 33(4):710-26. PubMed ID: 22498091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal event-related potentials in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Palmu K; Pitkonen M; Liljander S; Partanen JV; Akila R; Sainio M; Holm A
    Neurotoxicology; 2012 Aug; 33(4):703-9. PubMed ID: 22366255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic solvent-induced encephalopathy: course and prognostic factors of neuropsychological functioning.
    van Valen E; Wekking E; van Hout M; van der Laan G; Hageman G; van Dijk F; de Boer A; Sprangers M
    Int Arch Occup Environ Health; 2018 Oct; 91(7):843-858. PubMed ID: 29943196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of psychiatric disorders in patients with chronic solvent induced encephalopathy (CSE).
    Visser I; Wekking EM; de Boer AG; de Joode EA; van Hout MS; van Dorsselaer S; Ruhé HG; Huijser J; van der Laan G; van Dijk FJ; Schene AH
    Neurotoxicology; 2011 Dec; 32(6):916-22. PubMed ID: 21609732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.